Régis Ponte Conrado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Régis Ponte Conrado has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ana Camila Xavier Lopes
Universidade Federal do Ceará, Brasil
3 shared publications - Renato Mazon Lima Verde Leal
Universidade Federal do Ceará, Brasil
3 shared publications Annya Costa Araújo de Macedo Goes
Hospital Universitário Walter Cantídio, Brasil
2 shared publications- Ian Freire Castro
Hospital Geral de Fortaleza, Brasil
2 shared publications Marcelo Leite Vieira Costa
Hospital Universitário Walter Cantídio, Brasil
2 shared publications- Mariana Coelho Lima
Universidade Federal do Ceará, Brasil
2 shared publications
Latest Publications
- Open Access
- 28 May 2026
- Published by Springer Nature in Human Genome Variation
- Vol. 13 (1)
Carney complex with PRKAR1A variant and breast/fibrolamellar carcinomas
Carney complex is a rare multiple neoplasia syndrome caused primarily by inactivating variants in the PRKAR1A gene, which encodes the regulatory subunit type I alpha of protein kinase A. Although classically associated with myxomas, lentigines, and endocrine tumors, the full tumor spectrum related to PRKAR1A loss of function is not completely defined. Here, we report a patient with a molecularly confirmed diagnosis of Carney complex carrying a de novo PRKAR1A (NM_002734.5):c.348+1G>A splice-site variant. In addition to typical manifestations, the patient developed two uncommon malignancies: invasive breast carcinoma (luminal B-like) at a young age and fibrolamellar hepatocellular carcinoma lacking the DNAJB1–PRKACA fusion typically found in sporadic cases. The coexistence of these two rare tumors in a single carrier of a pathogenic PRKAR1A variant expands the phenotypic variability associated with this condition and supports the possibility that PRKAR1A loss contributes to oncogenesis beyond the classical endocrine and mesenchymal tissues. This Data Report provides clinically relevant documentation of an unusual tumor presentation associated with a pathogenic PRKAR1A variant and underscores the importance of ongoing clinical surveillance in affected individuals.
- 28 May 2026
- Published by Springer Nature in Human Genome Variation
- Vol. 13 (1)
Open AccessCarney complex with PRKAR1A variant and breast/fibrolamellar carcinomas
Carney complex is a rare multiple neoplasia syndrome caused primarily by inactivating variants in the PRKAR1A gene, which encodes the regulatory subunit type I alpha of protein kinase A. Although classically associated with myxomas, lentigines, and endocrine tumors, the full tumor spectrum related to PRKAR1A loss of function is not completely defined. Here, we report a patient with a molecularly confirmed diagnosis of Carney complex carrying a de novo PRKAR1A (NM_002734.5):c.348+1G>A splice-site variant. In addition to typical manifestations, the patient developed two uncommon malignancies: invasive breast carcinoma (luminal B-like) at a young age and fibrolamellar hepatocellular carcinoma lacking the DNAJB1–PRKACA fusion typically found in sporadic cases. The coexistence of these two rare tumors in a single carrier of a pathogenic PRKAR1A variant expands the phenotypic variability associated with this condition and supports the possibility that PRKAR1A loss contributes to oncogenesis beyond the classical endocrine and mesenchymal tissues. This Data Report provides clinically relevant documentation of an unusual tumor presentation associated with a pathogenic PRKAR1A variant and underscores the importance of ongoing clinical surveillance in affected individuals.
- Open Access
- 1 January 2023
- Published by Georg Thieme Verlag KG in Brazilian Journal of Oncology
- Vol. 19 (CP) , 1-9
Epithelial-mesenchymal transition in uterine carcinosarcoma from a dedifferentiated papillary serous carcinoma to a sarcoma: case report
Carcinosarcomas are endometrial neoplasms with malignant epithelial and mesenchymal components. These are rare tumors, corresponding to <5% of uterine cancers. The average age at diagnosis is 65 years and the most characteristic symptom is transvaginal bleeding, common to other uterine tumors. The definitive diagnosis of the lesion is done by analyzing the surgical specimen and the first-line treatment is surgery with adjuvant chemotherapy and radiotherapy. The authors report a case of a 59-year-old female diagnosed with a uterine carcinosarcoma, whose epithelial component underwent an epithelial-mesenchymal transition. The outstanding aspects of this report are the aggressiveness of this tumor and the presence of a lymph node metastasis by the sarcomatous component, which represents an unusual biological behavior.
- 1 January 2023
- Published by Georg Thieme Verlag KG in Brazilian Journal of Oncology
- Vol. 19 (CP) , 1-9
Open AccessEpithelial-mesenchymal transition in uterine carcinosarcoma from a dedifferentiated papillary serous carcinoma to a sarcoma: case report
Carcinosarcomas are endometrial neoplasms with malignant epithelial and mesenchymal components. These are rare tumors, corresponding to <5% of uterine cancers. The average age at diagnosis is 65 years and the most characteristic symptom is transvaginal bleeding, common to other uterine tumors. The definitive diagnosis of the lesion is done by analyzing the surgical specimen and the first-line treatment is surgery with adjuvant chemotherapy and radiotherapy. The authors report a case of a 59-year-old female diagnosed with a uterine carcinosarcoma, whose epithelial component underwent an epithelial-mesenchymal transition. The outstanding aspects of this report are the aggressiveness of this tumor and the presence of a lymph node metastasis by the sarcomatous component, which represents an unusual biological behavior.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 22, e20220108
Ressecção cirúrgica de leiomiossarcoma de veia cava inferior retro-hepática sem reconstrução vascular: relato de caso
Resumo O leiomiossarcoma de veia cava inferior (LVCI) é um raro tumor maligno mesenquimal. Seu tratamento cirúrgico é um desafio, pois necessita combinar margens cirúrgicas livres com reconstrução vascular, usando prótese ou enxerto autólogo, sutura primária ou ligadura simples sem reconstrução da veia. A ligadura é possível graças ao lento crescimento do tumor, permitindo o desenvolvimento de circulação venosa colateral. Apresentamos um caso de LVCI tratado por ressecção radical sem reconstrução vascular. Paciente feminina, 48 anos, com dor abdominal em hipocôndrio direito, astenia e sintomas dispépticos pós-prandiais. Tomografia de abdome revelou massa de formação expansiva localizada no segmento infra-hepático da veia cava inferior com redução da luz do vaso. Na cirurgia, o clampeamento da veia não indicou repercussões hemodinâmicas, sugerindo formação de circulação colateral suficiente. Decidiu-se pela ressecção radical em toda a porção da veia cava retro-hepática e ligadura da veia cava sem reconstrução vascular. A paciente evoluiu sem intercorrências.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 22, e20220108
Open AccessRessecção cirúrgica de leiomiossarcoma de veia cava inferior retro-hepática sem reconstrução vascular: relato de caso
Resumo O leiomiossarcoma de veia cava inferior (LVCI) é um raro tumor maligno mesenquimal. Seu tratamento cirúrgico é um desafio, pois necessita combinar margens cirúrgicas livres com reconstrução vascular, usando prótese ou enxerto autólogo, sutura primária ou ligadura simples sem reconstrução da veia. A ligadura é possível graças ao lento crescimento do tumor, permitindo o desenvolvimento de circulação venosa colateral. Apresentamos um caso de LVCI tratado por ressecção radical sem reconstrução vascular. Paciente feminina, 48 anos, com dor abdominal em hipocôndrio direito, astenia e sintomas dispépticos pós-prandiais. Tomografia de abdome revelou massa de formação expansiva localizada no segmento infra-hepático da veia cava inferior com redução da luz do vaso. Na cirurgia, o clampeamento da veia não indicou repercussões hemodinâmicas, sugerindo formação de circulação colateral suficiente. Decidiu-se pela ressecção radical em toda a porção da veia cava retro-hepática e ligadura da veia cava sem reconstrução vascular. A paciente evoluiu sem intercorrências.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 22, e20220108
Surgical resection of retrohepatic inferior vena cava leiomyosarcoma without vascular reconstruction: case report
Inferior vena cava leiomyosarcoma (IVCL) is a rare malignant mesenchymal tumor. Surgical treatment is a challenge because it must combine free surgical margins with vascular reconstruction, using prosthetic or autologous grafts, primary suture, or simple ligation without vein reconstruction. The ligation option is possible thanks to the slow growth of the tumor, allowing collateral venous circulation to develop. We present a case of an IVCL treated with radical resection without vascular reconstruction. The patient was a 48-year-old female with abdominal pain in the right upper quadrant, asthenia, and postprandial dyspeptic symptoms. Abdominal tomography revealed a mass with an expansive formation located in the infrahepatic segment of the inferior vena cava and reduced vessel lumen. During surgery, vein clamping did not provoke hemodynamic repercussions, suggesting sufficient collateral circulation formation. It was decided to perform a radical resection of the entire portion of the retrohepatic vena cava and ligate the vena cava without vascular reconstruction. The patient recovered without complications.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 22, e20220108
Open AccessSurgical resection of retrohepatic inferior vena cava leiomyosarcoma without vascular reconstruction: case report
Inferior vena cava leiomyosarcoma (IVCL) is a rare malignant mesenchymal tumor. Surgical treatment is a challenge because it must combine free surgical margins with vascular reconstruction, using prosthetic or autologous grafts, primary suture, or simple ligation without vein reconstruction. The ligation option is possible thanks to the slow growth of the tumor, allowing collateral venous circulation to develop. We present a case of an IVCL treated with radical resection without vascular reconstruction. The patient was a 48-year-old female with abdominal pain in the right upper quadrant, asthenia, and postprandial dyspeptic symptoms. Abdominal tomography revealed a mass with an expansive formation located in the infrahepatic segment of the inferior vena cava and reduced vessel lumen. During surgery, vein clamping did not provoke hemodynamic repercussions, suggesting sufficient collateral circulation formation. It was decided to perform a radical resection of the entire portion of the retrohepatic vena cava and ligate the vena cava without vascular reconstruction. The patient recovered without complications.